ﻻ يوجد ملخص باللغة العربية
Using the non-perturbative renormalization technique, we calculate the renormalization factors for quark bilinear operators made of overlap fermions on the lattice. The background gauge field is generated by the JLQCD and TWQCD collaborations including dynamical effects of two or 2+1 flavors of light quarks on a 16$^3times$32 or 16$^3times$48 lattice at lattice spacing around 0.1 fm. By reducing the quark mass close to the chiral limit, where the finite volume system enters the so-called $epsilon$-regime, the unwanted effect of spontaneous chiral symmetry breaking on the renormalization factors is suppressed. On the lattices in the conventional $p$-regime, this effect is precisely subtracted by separately calculating the contributions from the chiral condensate.
We present a calculation of the renormalization coefficients of the quark bilinear operators and the K-Kbar mixing parameter B_K. The coefficients relating the bare lattice operators to those in the RI/MOM scheme are computed non-perturbatively and t
High luminosity accelerators have greatly increased the interest in semi-exclusive and exclusive reactions involving nucleons. The relevant theoretical information is contained in the nucleon wavefunction and can be parametrized by moments of the nuc
We perform dynamical QCD simulations with $n_f=2$ overlap fermions by hybrid Monte-Carlo method on $6^4$ to $8^3times 16$ lattices. We study the problem of topological sector changing. A new method is proposed which works without topological sector c
We study QCD thermodynamics using two flavors of dynamical overlap fermions with quark masses corresponding to a pion mass of 350 MeV. We determine several observables on N_t=6 and 8 lattices. All our runs are performed with fixed global topology. Ou
The renormalization factors of local quark-bilinear operators are computed non-perturbatively for $N_f=3$ flavors of SLiNC fermions, with emphasis on the various procedures for the chiral and continuum extrapolations. The simulations are performed at